UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hemophilia: A Review of Perioperative Management for Cardiac Surgery

Journal of cardiothoracic and vascular anesthesia, 2022-01, Vol.36 (1), p.246-257

2022

Volltextzugriff (PDF)

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

British journal of haematology, 2023-01, Vol.200 (2), p.229-239

2023

Volltextzugriff (PDF)

Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty

Journal of the American Academy of Orthopaedic Surgeons, 2011-12, Vol.19 (12), p.768-776

2011

Volltextzugriff (PDF)

American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty

Journal of bone and joint surgery. American volume, 2012-04, Vol.94 (8), p.746-747

2012

Volltextzugriff (PDF)

Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-11, Vol.29 (6), p.1638-1645

2023

Volltextzugriff (PDF)

Treatment with Marstacimab for People with Severe Hemophilia a or B: a Plain Language Summary of the results from a short-term study and a longer-term study

Future Rare Diseases, 2023-12, Vol.3 (4)

2023

Volltextzugriff (PDF)

Fibrinogen Replacement Underutilization in ECMO

Blood, 2020-11, Vol.136 (Supplement 1), p.4-5

2020

Volltextzugriff (PDF)

Recombinant human factor VIIa in the management of amyloid‐associated factor X deficiency

British journal of haematology, 2001-03, Vol.112 (4), p.1074-1075

2001

Volltextzugriff (PDF)

In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice

Experimental hematology, 2011-05, Vol.39 (5), p.580-590.e1

2011

Volltextzugriff (PDF)

Using an educational intervention to assess and improve disease‐specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and B

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-03, Vol.27 (2), p.229-236

2021

Volltextzugriff (PDF)

Argatroban use in heparin-induced thrombocytopenia

Expert opinion on pharmacotherapy, 2008-08, Vol.9 (11), p.1963-1967

2008

Volltextzugriff (PDF)

High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-07, Vol.26 (4), p.637-642

2020

Volltextzugriff (PDF)

Long-Term Follow-up of Patients with Congenital Thrombotic Thrombocytopenia Purpura Receiving Plasma-Derived Factor VIII Containing (Koate®)

Blood, 2022-11, Vol.140 (Supplement 1), p.5644-5646

2022

Volltextzugriff (PDF)

The Clinical Spectrum of Thrombotic Thrombocytopenic Purpura

Seminars in thrombosis and hemostasis, 2005-12, Vol.31 (6), p.673-680

2005

Volltextzugriff (PDF)

Abnormalities in hemostasis in acute promyelocytic leukemia

Hematological oncology, 2002-03, Vol.20 (1), p.33-41

2002

Volltextzugriff (PDF)

Total Hip Arthroplasty for Avascular Necrosis in a Patient With Hemophilia B

Arthroplasty today, 2024-12, Vol.30, p.101482, Article 101482

2024

Volltextzugriff (PDF)

Thrombotic Events with NovoSeven® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Blood, 2018-11, Vol.132 (Supplement 1), p.1203-1203

2018

Volltextzugriff (PDF)

ACQUIRED HEMOPHILIA

Reviews in clinical and experimental hematology, 2001-12, Vol.5 (4), p.389-404

2001

Volltextzugriff (PDF)

Clinical and laboratory phenotype variability in type 2M von Willebrand disease

Journal of thrombosis and haemostasis, 2017-08, Vol.15 (8), p.1559-1566

2017

Volltextzugriff (PDF)

Presentation and Management of a Stage Ia Lung Cancer Patient With a Paraneoplastic Factor VIII Inhibitor

The Annals of thoracic surgery, 2006, Vol.81 (1), p.362-364

2006

Volltextzugriff (PDF)

Red blood cell exchange in patients with sickle cell disease—indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB

Transfusion (Philadelphia, Pa.), 2018-08, Vol.58 (8), p.1965-1972

2018

Volltextzugriff (PDF)

Dosing Factor in Pediatric and Adult Hemophilia Patients Using Ideal Body Weight Versus actual Body Weight

Blood, 2016-12, Vol.128 (22), p.4958-4958

2016

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(53)
Buchkapitel
(2)

Sprache

Englisch
(54)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A

Hemophilia: A Review of Perioperative Management for Cardiac Surgery

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty

Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13

Treatment with Marstacimab for People with Severe Hemophilia a or B: a Plain Language Summary of the results from a short-term study and a longer-term study

Fibrinogen Replacement Underutilization in ECMO

Recombinant human factor VIIa in the management of amyloid‐associated factor X deficiency

In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice

Using an educational intervention to assess and improve disease‐specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and B

Argatroban use in heparin-induced thrombocytopenia

High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice

Long-Term Follow-up of Patients with Congenital Thrombotic Thrombocytopenia Purpura Receiving Plasma-Derived Factor VIII Containing (Koate®)

The Clinical Spectrum of Thrombotic Thrombocytopenic Purpura

Abnormalities in hemostasis in acute promyelocytic leukemia

Total Hip Arthroplasty for Avascular Necrosis in a Patient With Hemophilia B

Thrombotic Events with NovoSeven® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

ACQUIRED HEMOPHILIA

Clinical and laboratory phenotype variability in type 2M von Willebrand disease

Presentation and Management of a Stage Ia Lung Cancer Patient With a Paraneoplastic Factor VIII Inhibitor

Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1

Red blood cell exchange in patients with sickle cell disease—indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB

Dosing Factor in Pediatric and Adult Hemophilia Patients Using Ideal Body Weight Versus actual Body Weight

Suchergebnisse filtern